Expired Manager Statistical Programming jobs in Bismarck, ND
avatar-of-creator
Loxo@Lilly
Manager, Programming, Scientific Systems
Bismarck, ND
$38,849-$141,687/year (est.)
About Loxo@Lilly: Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for...
Read More
avatar-of-creator
Sumitomo Pharma
Manager, Statistical Programming
Bismarck, ND
$99K-$131K / yr.
Manager, Statistical Programming Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s diverse...
Read More
BeiGene jobs
BeiGene
Senior Manager, Statistical Programming
Bismarck, ND
$74,734-$139,440/year (est.)
BeiGene continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in...
Read More
LabCorp jobs
LabCorp
Manager Stats Programming
Bismarck, ND
$38,849-$141,687/year (est.)
Manager, Statistical Programming required to work for Labcorp Drug Development. You will be employed by Labcorp Drug Development working in our late phase (II-IV) full-service group with the opportunity to work across multiple therapeutic areas Home based anywhere in the US or Canada. You must have...
Read More
avatar-of-creator
Sumitomo Pharma
Senior Manager, Statistical Programming
Bismarck, ND
$124K-$163K / yr.
Senior Manager, Statistical Programming Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s...
Read More